ADX-629 Therapy for Sjogren-Larsson Syndrome

NCT05443685 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Nebraska